Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-03-22
2011-03-22
McGarry, Sean (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
07910724
ABSTRACT:
This invention relates to compounds, compositions, and methods useful for modulating c-Fos gene expression using short interfering nucleic acid (siNA) molecules. This invention also relates to compounds, compositions, and methods useful for modulating the expression and activity of other genes involved in pathways of c-Fos gene expression and/or activity by RNA interference (RNAi) using small nucleic acid molecules. In particular, the instant invention features small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of c-Fos genes. The small nucleic acid molecules are useful in the treatment of cancer, proliferative diseases or conditions, inflammatory diseases or conditions, allergic diseases or conditions, infectious diseases or conditions, autoimmune diseases or conditions, or transplantation/allograft rejection in a subject or organism.
REFERENCES:
patent: 5814620 (1998-09-01), Robinson et al.
patent: 5985558 (1999-11-01), Dean et al.
patent: 5998203 (1999-12-01), Matulic-Adamic et al.
patent: 5998206 (1999-12-01), Cowsert
patent: 2003/0143732 (2003-07-01), Fosnaugh et al.
patent: 2004/0180351 (2004-09-01), Giese et al.
patent: 2004/0259247 (2004-12-01), Tuschl et al.
patent: 2005/0020521 (2005-01-01), Rana
patent: 2005/0080246 (2005-04-01), Allerson et al.
patent: 2359180 (2000-03-01), None
patent: WO90/14090 (1990-11-01), None
patent: WO94/01550 (1994-01-01), None
patent: WO99/32619 (1999-07-01), None
patent: WO99/49029 (1999-09-01), None
patent: WO00/44895 (2000-08-01), None
patent: WO00/44914 (2000-08-01), None
patent: WO01/36646 (2001-05-01), None
patent: WO01/96584 (2002-03-01), None
patent: WO02/22636 (2002-03-01), None
patent: WO02/44321 (2002-06-01), None
patent: WO03/064626 (2003-08-01), None
Allerson et al. (2005) “Fully 2′-Modified Oligonucleotide Duplexes with Improved in Vitro Potency and Stability Compared to Unmodified Small Interfering RNA” J. Med. Chemistry 48(4):901-904.
Van Straaten et al. (1983) Proc. Natl. Acad. Sci 80:3183-3187.
Amarzguioui et al. “Tolerance for mutations and chemical modifications in a siRNA” (Jan. 2003) Nucleic Acids Res. 31:589-595.
Parrish et al. “Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference” (2000) Mol. Cell 6:1077-1087.
Anderson et al. “Bispecific Short Hairpin siRNA Constructs Targeted to CD4, CXCR4, and CCR5 Confer HIV-1 Resistance,” Oligonucleotides 13(5):303-312 (2003).
Elbashir et al. “Analysis of Gene Function in Somatic Mammalian Cells Using Small Interfering RNAs,” Methods 26 (2):199-213 (2002).
Elbashir et al. “Duplexes of 21-Nucleotide RNAs Mediate RNA Interference in Cultured Mammalian Cells,” Nature 411(6836):494-498 (2001).
Elbashir et al. “Functional Anatomy of siRNAs for Mediating Efficient RNAi inDrosophila melanogasterEmbryo Lysate,” EMBO J. 20(23):6877-6888 (2001).
Elbashir et al. “RNA Interference is Mediated by 21- and 22-Nucleotide RNAs,” Genes Dev. 15(2):188-200 (2001).
Fire et al. “Potent and Specific Genetic Interference by Double-Stranded RNA inCaenorhabditis elegans,” Nature 391:806-811 (1998).
Futami et al. “Induction of Apoptosis in HeLa Cells with siRNA Expression Vector Targeted Against Bcl-2,” Nucleic Acids Research Supplement 2:251-252 (2002).
International Search Report mailed on Mar. 31, 2005 for PCT/US04/16390, 2 pages.
International Search Report mailed on Oct. 17, 2003 for PCT/US03105028, 2 pages.
International Search Report mailed on Oct. 17, 2003 for PCT/US03/05346, 1 page.
Leirdal et al. “Gene Silencing in Mammalian Cells by Preformed Small RNA Duplexes,” Biochemical and Biophysical Research Communications 295:744-748 (2002).
Lin et al. “A Novel mRNA-cDNA Interference Phenomenon for Silencing Bcl-2 Expression in Human LNCaP Cells,” Biochemical and Biophysical Research Communications 281:639-644 (2001).
Tuschl et al. “Small Interfering RNAs: A Revolutionary Tool for the Analysis of Gene Function and Gene Therapy,” Molecular Interventions 295(3):158-167 (2002).
Tuschl et al. “Targeted mRNA Degradation by Double-Stranded RNA in Vitro,” Genes and Development 13 (24):3191-3197 (1999).
Office Action mailed on Feb. 4, 2008 for U.S. Appl. No. 10/444,853, 37 pages.
Office Action mailed on Jul. 1, 2008 for U.S. Appl. No. 11/499,520, 13 pages.
Office Action mailed on Oct. 8, 2008 for U.S. Appl. No. 11/499,529, 34 pages.
Office Action mailed on Nov. 14, 2008 for U.S. Appl. No. 11/502,875, 14 pages.
Office Action mailed on Apr. 8, 2009 for U.S. Appl. No. 11/502,876, 31 pages.
Office Action mailed on Jan. 26, 2009 for U.S. Appl. No. 11/676,124, 15 pages.
Office Action mailed on Feb. 3, 2009 for U.S. Appl. No. 10/693,059, 7 pages.
Office Action mailed on Jul. 2, 2008 for U.S. Appl. No. 10/757,803, 26 pages.
Office Action mailed on Apr. 16, 2009 for U.S. Patent Appl. No. 12/105,010, 24 pages.
Request for Continued Examination with 1.14(c) Amendment filed May 10, 2007 in U.S. Appl. No. 10/923,115, 16 pages.
Final Office Action mailed Nov. 14, 2006 in U.S. Appl. No. 10/923,115, 15 pages.
1.111 Amendment filed Oct. 13, 2006 in U.S. Appl. No. 10/923,115, 7 pages.
Office Action mailed Jun. 13, 2006 in U.S. Appl. No. 10/923,115, 11 pages.
Shaw, et al., Nucleic Acids Res., vol. 19, pp. 747-750 (1991).
Beigelman Leonid
McSwiggen James
Gibbs Terra Cotta
Ginkel Laura M.
McGarry Sean
Muthard David A.
Sirna Therapeutics, Inc.
LandOfFree
RNA interference mediated inhibition of Fos gene expression... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with RNA interference mediated inhibition of Fos gene expression..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and RNA interference mediated inhibition of Fos gene expression... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2672479